Pricing Log in Create free account

Adaptimmune Therapeutics PLC (ADAPY) vs Citius Pharmaceuticals, Inc. (CTXR)

Adaptimmune Therapeutics PLC and Citius Pharmaceuticals, Inc. are both Biotechnology companies. Adaptimmune Therapeutics PLC and Citius Pharmaceuticals, Inc. are of similar size ($15.3M and $14.6M). Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −262.5%) and the lower return on invested capital (−58.7% vs 0.00%). Across the 13 metrics below, Citius Pharmaceuticals, Inc. leads on 7 and Adaptimmune Therapeutics PLC on 6.

Valuation

Metric ADAPY CTXR Biotechnology median
P/E n/m n/m 10.60
P/S 0.08 n/m 9.40
P/B n/m 0.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.08 n/m 9.02
Earnings yield (3,250.00%) (387.87%) (32.88%)
Free cash flow yield (3,648.13%) (242.31%) (23.13%)

Profitability

Metric ADAPY CTXR Biotechnology median
Gross margin 94.81% 0.00% 68.51%
Operating margin (427.75%) 0.00% 0.00%
Net margin (262.46%) 0.00% 0.00%
Free cash flow margin (294.49%) 0.00% 0.00%
Return on equity (1,349.52%) (64.51%) (51.96%)
Return on assets 0.00% (34.29%) (46.06%)
Return on invested capital 0.00% (58.74%) 0.00%

Growth

Metric ADAPY CTXR Biotechnology median
Revenue growth (TTM) (53.99%) — 6.76%
EPS growth (last fiscal year) 142.86% 43.38% 29.88%
Revenue growth, 5-year CAGR 8.40% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAPY CTXR Biotechnology median
Debt to equity (0.36) 0.08 0.00
Current ratio 1.52 0.84 4.97
Net debt to EBITDA 0.47 0.11 1.01

Dividend

Metric ADAPY CTXR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAPY CTXR Biotechnology median
Market cap 14.55m 15.31m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack